Vogenx director lists stock options at $0.93–$1.20
Vogenx, Inc. (VOGX) director Richard M. Gorman reported his beneficial ownership of stock options in an initial insider filing.
Rhea-AI Filing Summary
Vogenx, Inc. (VOGX) director Richard M. Gorman reported his beneficial ownership of stock options in an initial insider filing. He lists five Stock Option (right to buy) positions over Vogenx common stock with exercise prices of $0.93, $1.14, and $1.20 per share, expiring between 2032 and 2036. Some options covering 8,333 underlying shares at $0.93 and $1.14 are fully vested and exercisable, while others over 3,333 underlying shares at $1.20 vest in three equal annual installments on specified dates, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Gorman Richard M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F2 | -- | -- | -- |
| holding | Stock Option (right to buy) F3 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 26,665 contracts (Direct)
Footnotes (3)
- F1. The shares subject to this option are fully vested and exercisable as of the date hereof.
- F2. The shares subject to this option vest as to 1,111 shares on January 26, 2025, 1,111 shares on January 26, 2026 and 1,111 shares on January 26, 2027, subject to the Reporting Person's continued service on each such vesting date.
- F3. The shares subject to this option vest as to 1,111 shares on January 26, 2026, 1,111 shares on January 26, 2027 and 1,111 shares on January 26, 2028, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Underlying shares at $0.93 expiring 2032-07-27: 8,333 shares
Underlying shares at $0.93 expiring 2033-01-25: 3,333 shares
Underlying shares at $1.20 expiring 2034-01-27: 3,333 shares
+4 more
7 metrics
Underlying shares at $0.93 expiring 2032-07-27
8,333 shares
Stock Option (right to buy) with $0.93 exercise price, expiration 2032-07-27
Underlying shares at $0.93 expiring 2033-01-25
3,333 shares
Stock Option (right to buy) with $0.93 exercise price, expiration 2033-01-25
Underlying shares at $1.20 expiring 2034-01-27
3,333 shares
Stock Option (right to buy) with $1.20 exercise price, expiration 2034-01-27
Underlying shares at $1.20 expiring 2035-01-27
3,333 shares
Stock Option (right to buy) with $1.20 exercise price, expiration 2035-01-27
Underlying shares at $1.14 expiring 2036-01-01
8,333 shares
Stock Option (right to buy) with $1.14 exercise price, expiration 2036-01-01
Vesting tranche size in $1.20 options
1,111 shares
Each vesting date for certain $1.20 options vests 1,111 shares
Exercise price (fully vested options)
$0.93 and $1.14 per share
Options with these exercise prices are fully vested and exercisable
Key Terms
Stock Option (right to buy), exercise price, fully vested and exercisable, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: "0.9300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
fully vested and exercisable financial
"The shares subject to this option are fully vested and exercisable"
vesting financial
"The shares subject to this option vest as to 1,111 shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does VOGX’s Form 3 filing by Richard M. Gorman report?
It reports that director Richard M. Gorman beneficially owns several stock options on Vogenx, Inc. common stock, detailing the exercise prices, expiration dates, and underlying share amounts, along with vesting schedules tied to his continued service.
What are the exercise prices of the stock options reported by Richard M. Gorman for VOGX?
The reported stock options have exercise prices of $0.93, $1.14, and $1.20 per share, each relating to options to purchase Vogenx, Inc. common stock under different option awards and vesting schedules.
When do Richard M. Gorman’s reported VOGX stock options expire?
The stock options expire on July 27, 2032, January 25, 2033, January 27, 2034, January 27, 2035, and January 1, 2036, depending on the individual option grant described in the filing.
How do the vesting schedules work for the $1.20 VOGX stock options reported by Richard M. Gorman?
For the $1.20 options, footnotes state that 1,111 shares vest on each of three annual dates (for one grant: January 26, 2025, 2026, 2027; for another: January 26, 2026, 2027, 2028), in each case conditional on his continued service on the vesting dates.
Does the Form 3 for VOGX show any recent stock purchases or sales by Richard M. Gorman?
No. The Form 3 lists holdings of stock options and their terms but does not report any buy or sell transactions; transaction codes and share amounts for trades are not provided.
AI-generated analysis. How Rhea-AI works. Not financial advice.
